MELBOURNE, Australia, March 30, 2026 /PRNewswire/ -- 4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has ...
DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, today announced that CT:VQ™ technology has ...
Educating physicians about ventilation-perfusion scanning as an alternative to CT for the diagnosis of pulmonary embolisms led to a 23 percent decrease in patient exposure, according to a study ...
4DMedical Limited has unveiled its innovative CT:VQ technology at RSNA 2024, offering a revolutionary alternative to traditional Nuclear VQ scans. This new imaging solution promises faster, safer, and ...
Thank you for standing by, and welcome to the 4DMedical Investor Webinar. I would now like to hand the conference over to John Hester, Senior Analyst at Bell Potter. Please go ahead. Thank you. Thank ...
LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world's first ...
Hey everybody. Really, thank you so much for joining this call. I'm incredibly appreciative of your interest. I hope you can bear with me. My voice is pretty hoarse. I've literally had hundreds and ...
In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 30, ...
Non-contrast, ventilation-perfusion imaging-from routine chest CT scansMELBOURNE, Australia, June 29, 2026 /PRNewswire/ -- 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results